BENITEC BIOPHARMA INC (BNTC)
US08205P2092 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to BNTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 25.94. This target is 149.88% above the current price.
BNTC was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about BNTC.
In the previous month the buy percentage consensus was at a similar level.
BNTC was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-13 | Baird | Initiate | Outperform |
| 2024-12-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-10-16 | Oppenheimer | Initiate | Outperform |
| 2024-10-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-09-30 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-12 | Guggenheim | Initiate | Buy |
| 2024-07-22 | Leerink Partners | Initiate | Outperform |
| 2024-06-13 | Piper Sandler | Initiate | Overweight |
| 2024-04-22 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-02-15 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-01-24 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-09-26 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-06-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-05-18 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2022-10-18 | JMP Securities | Initiate | Market Outperform |
| 2022-09-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-17 | HC Wainwright & Co. | Initiate | Buy |